Publications by authors named "L Vedin"

Liver X receptors (LXRs) are nuclear transcription factors important in the regulation of cholesterol transport, and glucose and fatty acid metabolism. The antiproliferative role of LXRs has been studied in a variety of malignancies and may represent a therapeutic opportunity in cancers lacking targeted therapies, such as triple-negative breast cancer. In this study, we investigated the impact of LXR agonists alone and in combination with carboplatin in preclinical models of breast cancer.

View Article and Find Full Text PDF

The synchronization of circadian clock depends on a central pacemaker located in the suprachiasmatic nuclei. However, the potential feedback of peripheral signals on the central clock remains poorly characterized. To explore whether peripheral organ circadian clocks may affect the central pacemaker, we used a chimeric model in which mouse hepatocytes were replaced by human hepatocytes.

View Article and Find Full Text PDF

Background: Sterol O-acyltransferase 2 (Soat2) encodes acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2), which synthesizes cholesteryl esters in hepatocytes and enterocytes fated either to storage or to secretion into nascent triglyceride-rich lipoproteins.

Objectives: We aimed to unravel the molecular mechanisms leading to reduced hepatic steatosis when Soat2 is depleted in mice.

Methods: Soat2 and wild-type mice were fed a high-fat, a high-carbohydrate, or a chow diet, and parameters of lipid and glucose metabolism were assessed.

View Article and Find Full Text PDF

Background And Aims: Genetically modified mice have been used extensively to study human disease. However, the data gained are not always translatable to humans because of major species differences. Liver-humanized mice (LHM) are considered a promising model to study human hepatic and systemic metabolism.

View Article and Find Full Text PDF
Article Synopsis
  • Obesity leads to non-alcoholic fatty liver disease (NAFLD) by changing the regulatory networks and epigenomes in liver cells.
  • The study shows that G protein pathway suppressor 2 (GPS2) plays a key role in these changes and hastens the transition from NAFLD to non-alcoholic steatohepatitis (NASH).
  • Knocking out GPS2 in liver cells of mice reduces fat accumulation and fibrosis while activating genes that break down lipids, suggesting that the GPS2-PPARα relationship might be a potential target for therapy in NAFLD and NASH.
View Article and Find Full Text PDF